VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA
Open Access
- 1 December 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 40 (D1) , D230-D236
Abstract
RNAi technology has been emerging as a potential modality to inhibit viruses during past decade. In literature a few siRNA databases have been reported that focus on targeting human and mammalian genes but experimentally validated viral siRNA databases are lacking. We have developed VIRsiRNAdb, a manually curated database having comprehensive details of 1358 siRNA/shRNA targeting viral genome regions. Further, wherever available, information regarding alternative efficacies of above 300 siRNAs derived from different assays has also been incorporated. Important fields included in the database are siRNA sequence, virus subtype, target genome region, cell type, target object, experimental assay, efficacy, off-target and siRNA matching with reference viral sequences. Database also provides the users with facilities of advance search, browsing, data submission, linking to external databases and useful siRNA analysis tools especially siTarAlign which align the siRNA with reference viral genomes or user defined sequences. VIRsiRNAdb contains extensive details of siRNA/shRNA targeting 42 important human viruses including influenza virus, hepatitis B virus, HPV and SARS Corona virus. VIRsiRNAdb would prove useful for researchers in picking up the best viral siRNA for antiviral therapeutics development and also for developing better viral siRNA design tools. The database is freely available at http://crdd.osdd.net/servers/virsirnadb.Keywords
This publication has 47 references indexed in Scilit:
- A status report on RNAi therapeuticsSilence, 2010
- RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34 + Cells in Patients Undergoing Transplantation for AIDS-Related LymphomaScience Translational Medicine, 2010
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virusProceedings of the National Academy of Sciences, 2010
- Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus InfectionScience, 2010
- Thermodynamic stability and Watson–Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effectNucleic Acids Research, 2008
- Experimental validation of the importance of seed complement frequency to siRNA specificityRNA, 2008
- siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infectionJournal of Drug Targeting, 2008
- Optimal design and validation of antiviral siRNA for targeting HIV-1Retrovirology, 2007
- siVirus: web-based antiviral siRNA design software for highly divergent viral sequencesNucleic Acids Research, 2006
- Expression profiling reveals off-target gene regulation by RNAiNature Biotechnology, 2003